Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Aquila reveals new product in pipeline: CD1-TB

April 5, 1999

Merck & Co. presents new macrolide immunosuppressants

April 1, 1999

Aquila initiates phase IIb testing of Quilimmune-P

April 1, 1999

New patent expands protection for BioTransplant's AlloMune and XenoMune systems

March 23, 1999

Collaboration between Wyeth and Aviron for FluMist effective immediately

March 23, 1999

German launch announced for Novartis immunosuppressant

March 22, 1999

Novel tacrolimus (FK-506) prodrug expected to have superior therapeutic activity

March 22, 1999

Antex Chlamydia vaccine shows promise in animal study

March 19, 1999

Immunomodulatory effects of sinomenine, an alkaloid compound of plant origin

March 18, 1999

Corixa's LeIF adjuvant is protected by three new U.S. patents

March 16, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....